The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 3.

Table. 3.

Transfusion indications entered when PLT products were ordered

Transfusion Indications of PLTs (PC, SDP)Platelet countsN (%)
Bleeding≥50,000/μL2743 (24.6)
≥100,000/μL391 (3.5)
Bleeding prevention
 Hematologic disease≥10,000/μL1107 (9.9)
≥20,000/μL2325 (20.8)
 Solid tumor≥10,000/μL641 (5.7)
≥20,000/μL563 (5.1)
 PBSCT≥20,000/μL286 (2.6)
 Disseminated intravascular coagulopathy≥50,000/μL699 (6.3)
 Infant≥30,000/μL 2 (0.0)
≥50,000/μL90 (0.8)
≥100,000/μL13 (0.1)
Surgery/Procedure≥50,000/μL868 (7.8)
≥80,000/μL56 (0.5)
≥100,000/μL215 (1.9)
Massive transfusion≥100,000/μL303 (2.7)
Others856 (7.7)
Total11158 (100)
Korean J Blood Transfus 2019;30:138-47 https://doi.org/10.17945/kjbt.2019.30.2.138
© 2019 Korean J Blood Transfus